Company

Pear Therapeutics

vendor1 tracked tool

clinical_documentation category intelligence

Tracked Tools by Pear Therapeutics

Pear Therapeutics was a pioneer in prescription digital therapeutics (PDTs), developing FDA-authorized software-based treatments for substance use disorders (reSET, reSET-O) and chronic insomnia (Somryst). The company's products were prescribed by physicians and delivered evidence-based cognitive behavioral therapy through mobile apps. Pear Therapeutics filed for bankruptcy in April 2023 despite being first-to-market with FDA-authorized PDTs, highlighting commercial challenges in the digital therapeutics space.

Company Intelligence

Pear Therapeutics assets sold at auction for $6.05 million following Chapter 11 bankruptcy

2 months agodeployment

CodeLink Partners with Pear Therapeutics to Scale Development and Quality Assurance for reSET and reSET-O

2 months agopartnership

PursueCare Acquires and Relaunches reSET and reSET-O Programs

2 months agofda

‘We don’t think of it as just a service line’: How 5 health systems integrate behavioral health into core finances

3 months agodeployment

STAT+: FDA appears open to Moderna's flu vaccine ahead of adcomm

3 months agofda

From Copilots to Clinical Judgment: The Next Phase of AI in Digital Behavioral Health

3 months agodeployment

Pear Therapeutics and BrightView Expand Digital Treatment Pilot

4 months agopartnership

Pear Therapeutics Reports Third Quarter 2022 Results

4 months agodeployment

Providence hospital to lay off 40 workers amid behavioral health staffing overhaul

4 months agodeployment

AI-augmented behavioral health provider Theris launches out of stealth

4 months agostartup

Greatly Health Secures $4M to Scale MSK-Validated Integrative Oncology Platform

5 months agoevidence

Pear Therapeutics Files for Chapter 11 Bankruptcy Amid Financial Struggles

5 months agodeployment

Pear Therapeutics' Assets Sold for $6 Million in Bankruptcy Auction

5 months agofda

Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst®

5 months agodeployment

Nine-Month Data Boosts Pear’s Opioid Treatment PDT

5 months agodeployment